<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04978701</url>
  </required_header>
  <id_info>
    <org_study_id>NFEC-2021-220</org_study_id>
    <nct_id>NCT04978701</nct_id>
  </id_info>
  <brief_title>Dynamic Changes of the Human Microbiome Predict the Risk of Poor Prognosis in Patients With Acute Ischemic Stroke: a Multi-center Study</brief_title>
  <official_title>Dynamic Changes of the Human Microbiome Predict the Risk of Poor Prognosis in Patients With Acute Ischemic Stroke: a Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zhujiang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Yanling Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Hospital Of Qiqihar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huzhou Central Hospital, Zhejiang Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang Greentown Cardiovascular Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Leshan, Sichuan Province</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies have found a close relationship between acute ischemic stroke(AIS) and gut&#xD;
      microbiota, but whether the dynamic changes in human microbiome after stroke can predict poor&#xD;
      prognosis of stroke remains unclear. Therefore, we planned to explore the predictive value of&#xD;
      human microbiome and its metabolites in stroke prognosis through a multicenter cohort study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was designed as a prospective, observational, multicenter cohort study. 2000&#xD;
      patients with AIS will be enrolled continuously through multiple centers. Oral swabs, feces&#xD;
      (the day after admission, 1 month, 3 months after the onset of disease) and blood samples&#xD;
      (the day after admission, 3 months after the onset of disease) will be collected. After the&#xD;
      onset of the disease (1 month, 3 months, 6 months and 12 months), outpatient/telephone&#xD;
      follow-up will be conducted to evaluate the neurological function scores of the patients, and&#xD;
      the recurrence of stroke and other cardio-cerebrovascular events will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>3 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>National Institute of Health stroke scale</measure>
    <time_frame>3 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major ischemic events</measure>
    <time_frame>within 3 months</time_frame>
    <description>Major ischemic event is defined as ischemic stroke, myocardial infarction, or death from an ischemic vascular event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>6 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health stroke scale</measure>
    <time_frame>6 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major ischemic events</measure>
    <time_frame>within 6 months</time_frame>
    <description>Major ischemic event is defined as ischemic stroke, myocardial infarction, or death from an ischemic vascular event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Scale</measure>
    <time_frame>12 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>National Institute of Health stroke scale</measure>
    <time_frame>12 months after the onset</time_frame>
    <description>An evaluation of neurological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major ischemic events</measure>
    <time_frame>within 12 months</time_frame>
    <description>Major ischemic event is defined as ischemic stroke, myocardial infarction, or death from an ischemic vascular event.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood plasm；Faeces；Oral swabs&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who met the eligibility criteria for acute ischemic stroke&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meet the AIS diagnostic criteria;&#xD;
&#xD;
          -  Age 18-80;&#xD;
&#xD;
          -  Within 7 days of the onset;&#xD;
&#xD;
          -  Signing the informed consent, providing relevant medical history and biological&#xD;
             specimens.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  mRS &gt; score 2 before onset;&#xD;
&#xD;
          -  Serious systemic diseases including malignant tumors;&#xD;
&#xD;
          -  Hematological diseases and autoimmune diseases;&#xD;
&#xD;
          -  ALT or AST &gt; 2 times the upper limit of normal value or severe liver disease;&#xD;
&#xD;
          -  Serum creatinine &gt; 1.5 times the upper normal limit or severe nephropathy;&#xD;
&#xD;
          -  History of alcoholism, drug abuse, and chemical poisoning (e.g. pesticide poisoning);&#xD;
&#xD;
          -  History of intestinal tumor, irritable bowel syndrome or inflammatory bowel disease or&#xD;
             confirmed in hospital;&#xD;
&#xD;
          -  Antibiotic use within 1 month before admission;&#xD;
&#xD;
          -  Fece cannot be obtained within 4 days after admission.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yin Jia, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, NanFang Hospital, Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yin Jia, Master</last_name>
    <phone>+86 13802964883</phone>
    <email>jiajiayin@139.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhang Mingsi, Master</last_name>
    <phone>+86 13827003570</phone>
    <email>meens19@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology, NanFang Hospital, Southern Medical University</name>
      <address>
        <city>Guanzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yin Jia, master's degree</last_name>
      <phone>+8613802964883</phone>
      <email>jiajiayin@139.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhang Mingsi</last_name>
      <phone>+8613827003570</phone>
      <email>meens@qq.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 20, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanfang Hospital of Southern Medical University</investigator_affiliation>
    <investigator_full_name>yinjia</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>acute ischemic stroke, microbiome, prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

